S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Cyclo Therapeutics (CYTH) Short Interest Ratio & Short Volume

$1.75
+0.06 (+3.55%)
(As of 02/23/2024 ET)

Cyclo Therapeutics Short Interest Data

Current Short Volume
158,900 shares
Previous Short Volume
196,800 shares
Change Vs. Previous Month
-19.26%
Dollar Volume Sold Short
$300,321.00
Short Interest Ratio / Days to Cover
1.5
Last Record Date
January 31, 2024
Outstanding Shares
22,730,000 shares
Float Size
10,670,000 shares
Short Percent of Float
1.49%
Today's Trading Volume
17,511 shares
Average Trading Volume
82,771 shares
Today's Volume Vs. Average
21%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cyclo Therapeutics ?

Sign up to receive the latest short interest report for Cyclo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CYTH Short Interest Over Time

CYTH Days to Cover Over Time

CYTH Percentage of Float Shorted Over Time


Cyclo Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024158,900 shares $300,321.00 -19.3%1.5%1.5 $1.89
1/15/2024196,800 shares $366,048.00 -40.6%1.8%2.1 $1.86
12/31/2023331,200 shares $526,608.00 +83.3%3.1%3.9 $1.59
12/15/2023180,700 shares $247,559.00 -16.7%1.7%2.3 $1.37
11/30/2023216,900 shares $312,336.00 -2.7%2.5%4 $1.44
11/15/2023223,000 shares $323,350.00 +76.4%2.6%4 $1.45
10/31/2023126,400 shares $119,448.00 -5.0%1.7%2.4 $0.95
10/15/2023133,000 shares $140,980.00 -3.1%1.3%2.6 $1.06
9/30/2023137,200 shares $194,824.00 +3.1%1.3%2.6 $1.42
9/15/2023133,100 shares $234,256.00 -31.3%1.3%2.4 $1.76
8/31/2023193,800 shares $322,677.00 -15.6%2.4%2.3 $1.67
8/15/2023229,600 shares $307,664.00 +1.7%2.8%2.5 $1.34
7/31/2023225,700 shares $349,835.00 +139.1%3.5%2.4 $1.55
7/15/202394,400 shares $137,824.00 +93.8%0.9%0.6 $1.46
6/30/202348,700 shares $77,433.00 -43.9%0.5%0.3 $1.59
6/15/202386,800 shares $183,148.00 +40.7%0.8%0.6 $2.11
5/31/202361,700 shares $74,657.00 +11.8%0.8%0.4 $1.21
5/15/202355,200 shares $58,517.52 No Change0.7%0.4 $1.06
10/31/202213,700 shares $25,893.00 +29.3%0.2%0.4 $1.89
10/15/202210,600 shares $19,080.00 -53.7%0.1%0.4 $1.80
9/30/202222,900 shares $44,197.00 +536.1%0.3%0.8 $1.93
9/15/20223,600 shares $6,948.00 +200.0%0.1%0.2 $1.93
8/31/20221,200 shares $2,544.00 -86.5%0.0%0.1 $2.12
8/15/20228,900 shares $22,072.00 +187.1%0.1%0.4 $2.48
7/31/20223,100 shares $6,107.00 +138.5%0.0%0.1 $1.97
7/15/20221,300 shares $2,782.00 -40.9%0.0%0.1 $2.14
6/30/20222,200 shares $4,334.00 -76.1%0.0%0.1 $1.97
6/15/20229,200 shares $19,320.00 +31.4%0.1%0.3 $2.10
5/31/20227,000 shares $16,100.00 +125.8%0.1%0.2 $2.30
5/15/20223,100 shares $6,541.00 -49.2%0.0%0.1 $2.11
4/30/20226,100 shares $16,348.00 -77.2%0.1%0.1 $2.68
4/15/202226,700 shares $73,692.00 -58.3%0.4%0.5 $2.76
3/31/202264,000 shares $202,880.00 +257.5%N/A1 $3.17
3/15/202217,900 shares $46,898.00 +129.5%0.2%0.3 $2.62
2/28/20227,800 shares $25,428.00 -59.8%0.1%0.1 $3.26
2/15/202219,400 shares $66,930.00 -16.7%0.3%0.2 $3.45
1/31/202223,300 shares $85,744.00 -2.1%0.3%0.1 $3.68
1/15/202223,800 shares $100,912.00 -35.0%0.3%0.1 $4.24
12/31/202136,600 shares $136,518.00 -38.9%0.5%0.2 $3.73
12/15/202159,900 shares $241,397.00 +5.1%0.8%0.4 $4.03













CYTH Short Interest - Frequently Asked Questions

What is Cyclo Therapeutics' current short interest?

Short interest is the volume of Cyclo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 158,900 shares of CYTH short. 1.49% of Cyclo Therapeutics' shares are currently sold short. Learn More on Cyclo Therapeutics' current short interest.

What is a good short interest ratio for Cyclo Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYTH shares currently have a short interest ratio of 2.0. Learn More on Cyclo Therapeutics's short interest ratio.

Which institutional investors are shorting Cyclo Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cyclo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Cyclo Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.49% of Cyclo Therapeutics' floating shares are currently sold short.

Is Cyclo Therapeutics' short interest increasing or decreasing?

Cyclo Therapeutics saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 158,900 shares, a decline of 19.3% from the previous total of 196,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cyclo Therapeutics' float size?

Cyclo Therapeutics currently has issued a total of 22,730,000 shares. Some of Cyclo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cyclo Therapeutics currently has a public float of 10,670,000 shares.

How does Cyclo Therapeutics' short interest compare to its competitors?

1.49% of Cyclo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cyclo Therapeutics: Estrella Immunopharma, Inc. (0.33%), Dyadic International, Inc. (0.85%), Gamida Cell Ltd. (8.39%), OKYO Pharma Limited (0.28%), Achilles Therapeutics plc (0.03%), Protara Therapeutics, Inc. (1.06%), IN8bio, Inc. (0.53%), MiNK Therapeutics, Inc. (1.97%), Pluri Inc. (0.71%), Aligos Therapeutics, Inc. (1.19%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Cyclo Therapeutics stock?

Short selling CYTH is an investing strategy that aims to generate trading profit from Cyclo Therapeutics as its price is falling. CYTH shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cyclo Therapeutics?

A short squeeze for Cyclo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CYTH, which in turn drives the price of the stock up even further.

How often is Cyclo Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYTH, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CYTH) was last updated on 2/23/2024 by MarketBeat.com Staff